April 13, 2016

The legislation, advocated by both retail pharmacy and the pharma industry, would advance collaboration among health and enforcement authorities to achieve drug abuse solutions that maintain patients’ legitimate access to medications.

April 12, 2016

A new report from Accenture is shedding light on a new focus on the part of pharmaceutical companies: investing in patient-centered capabilities and services.

April 12, 2016

The company said it uses web-based pharmacy benefit system MERLIN, which has 16 integrated modules that can aid in personalizing service for each client.

April 11, 2016

California pharmacists are authorized to furnish oral, transdermal, vaginal and Depo injection forms of prescription birth control under a new law that took effect April 8. 

April 11, 2016

The launch makes Mylan the only manufacturer with five strengths for its generic Lopressor, a treatment for hypertension.

April 11, 2016

When implementation of Walgreens' naloxone program is complete, naloxone will be available without a prescription in more than 5,800 of Walgreens nearly 8,200 stores.

April 7, 2016

 The drug is indicated to treat cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome, as well as to prevent CMV in high-risk kidney, heart, or kidney-pancreas transplant.

April 7, 2016

Lamivudine tablets had U.S. sales of about $27.1 million for the 12 months ended December 2015.

April 7, 2016

The letter points out that copay increases place financial burdens on TRICARE beneficiaries and restrict patient access. In addition, restricting patient access could adversely impact medication compliance and actually increase health costs. 

April 7, 2016

So far in 2016, there have been multiple Part D plans and PBMs that have been utilizing MAC drug pricing values that are "far below what would be considered to be reasonably approaching market prices for drugs," the letter noted.

April 6, 2016

Lupin on Wednesday announced the appointment of Dr. Kurt Nielsen as president of Lupin-Somerset.

April 6, 2016
Lupin received final approval for Zolpidem Sublingual Tablets from the United States Food & Drug Administration earlier, as well as final clearance from the FTC with 180 days of exclusivity.
 
April 6, 2016

Hospira, now a Pfizer company, entered into an agreement with Celltrion and Celltrion Healthcare in 2009 for several potential biosimilar products, including the recently-approved Inflectra.

April 5, 2016
ANI Pharmaceuticals on Tuesday announced the Food and Drug Administration approval for one new generic and the launch of another. 
April 5, 2016

Global Citizen is reporting that GlaxoSmithKline will be granting licenses to generics manufacturers in lower middle-income countries in a move aimed at increasing access to medicine in low-income countries. The company announced the changes at the end of March, noting that rather than attempting to enforce its patents, it would move to a licensing model, charging a small fee to generics manufacturers. (Global Citizen)

April 4, 2016
The drug had annual sales of about $26.2 million for the 12 months ended February 2016, according to IMS Health. 
April 4, 2016

The study found that Walgreens pharmacy patients who used a multi-faceted medication adherence program had a 3% higher medication adherence rate and lower healthcare costs than those who use other pharmacies.

April 1, 2016

However, flu activity is still relatively high across Wyoming, Montana and Kentucky, according to the report. 

April 1, 2016
The report attributes the growth to a concurrent increase in chronic pain in the United States, stemming from an aging population and more incidences of such chronic diseases as diabetes, obesity, cancer, arthritis and cardiovascular disease. 
April 1, 2016

Deloitte’s new whitepaper, “Retail health & wellness: Innovation, convergence and healthier consumers” offers background and insights into how and why retailers are making the large shift toward more robust health and wellness offerings. 

March 31, 2016

The complaint alleges that Endo paid Impax Laboratories and Watson Laboratories, which were the first companies to file for FDA approval for generics of Endo’s Opana ER and Lidoderm, to delay their generic product launches. 

March 31, 2016

The $550 million acquisition is aimed at strengthening Humanwell and PuraCap’s U.S. generics footprint and manufacturing capabilities. 

March 30, 2016

Recognizing that an estimated 40% of sold medications end up unused, the Alliance for Aging Research's latest “pocket film” offers consumers a simple step-by-step guide on safe disposal. 

March 29, 2016

The drug had annual U.S. sales of about $52.8 million for the 12 months ended Dec. 31, 2015, according to IMS Health.